DC
DERM icon

Diametric Capital’s Journey Medical DERM Stock Holding History

Diametric Capital’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.09M Buy
295,663
+99,251
+51% +$567K 0.22% 80
2026
Q1 		$921K Buy
196,412
+144,729
+280% +$1.12M 0.24% 111
2025
Q4 		$398K Buy
+51,683
New +$405K 0.11% 275

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Diametric Capital's DERM Position: Q2 2026 in Review

Diametric Capital increased its Journey Medical (DERM) stake by 51% in Q2 2026, buying an estimated $567K and bringing the position to 295,663 shares worth $2.09M. The position accounts for 0.22% of the portfolio, ranked #80.

Diametric Capital first reported a position in DERM in Q4 2025 and has held it in 3 quarters since. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Diametric Capital held 295,663 shares of Journey Medical worth $2.09M as of Q2 2026.
  • Diametric Capital bought 99,251 Journey Medical shares in Q2 2026, an estimated $567K.
  • Journey Medical made up 0.22% of Diametric Capital's portfolio in Q2 2026, its #80 holding.
  • Diametric Capital first reported a position in Journey Medical in Q4 2025 and has held it in 3 quarters since.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Diametric Capital's 13F filing for Q2 2026, filed 14 Aug 2026.